Can Strive Pharmacy handle GLP-1 and peptide stacks for one patient?

Strive Pharmacy is well positioned for combined programs on formulary breadth alone — semaglutide/glycine/B12 and tirzepatide/glycine/B12 sit alongside sermorelin, NAD+, GHK-Cu, and glutathione in the same catalog. For a clinic whose entire combined-program stack is Strive SKUs, one prescriber portal covers both molecule families without separate pharmacy relationships.

The gaps to confirm are multi-line workflow and pricing. Ask whether a patient's GLP-1 and peptide lines submit in one session or require separate orders. Ask whether per-vial cost on both molecule families is available through pricing@strivepharmacy.com before you price the combined program — GLP-1 margin and peptide margin may differ, and you need both numbers.

Combined programs multiply ordering risk. A wrong GLP-1 titration dose and a peptide SIG error in the same patient order both cause rejections — but they fail for different reasons and at different points in the workflow. Ask whether validation runs across all lines before payment, not just the first compound submitted.

Fizy Health is an ordering platform — not a compounder — that stacks GLP-1 and peptide lines for the same patient in one validated cart. Per-vial cost shows on every line before checkout, validation catches SIG and licensure issues across the full stack before payment, and if any line routes to a different 503A partner, Fizy Health handles the split after one checkout.